Recently, the working meeting of the Medical Artificial Intelligence Committee of the Chinese Artificial Intelligence Industry Development Alliance was held in Haikou. At the meeting, the first batch of "Panorama of High-quality Development of Digital Medical Products and Services" was released, and Rongke Technology and its member companies Rongke Zhiweiyun, Mijian Medical, Shenzhou Shihan, and Jinchuang Technology were honorably selected with their outstanding scientific research strength and excellent product quality, with nine self-developed products such as Rongjia Houqin ™, "Long-term Care Insurance" service platform, critical care medical clinical information system, triage management system, and electronic medical record quality control system, demonstrating the profound heritage and outstanding achievements of Rongke Group in the medical field with their strength.
Rongke Technology was selected for the certificate
The member companies of Rongke Technology were selected for the certificate
The Panorama of High-Quality Development of Digital Medical Products and Services was compiled and released by the China Academy of Information and Communications Technology. As an authoritative information and communication technology research institution in China, the China Academy of Information and Communications Technology (CAICT) draws a panorama of products and services by combing the information products, services, solutions and enterprise ecology of the medical and health industry, further researching and judging the product classification and distribution trend, gaining insight into the development trend of the industry, and providing an important reference for the sustainable development and innovation of the digital health industry.
Rongke Technology has always adhered to the development concept of "making health simpler and making cities smarter", and has been deeply engaged in smart medical care with its member companies for many years, and has provided information products and solutions for more than 80% of the "top 100 hospitals" and more than 4,000 medical institutions in mainland China, which has been highly praised by customers.
The selection of the first batch of medical products is not only a recognition of the technical strength and product quality of Rongke Group, but also an encouragement and encouragement. Rongke Group will take this opportunity to adhere to the innovation-driven development strategy, play a leading role in technology, continue to enrich and complete the group of medical products and solutions, build a solid foundation for people's health, and contribute to the high-quality and rapid development of the medical industry in mainland China.